Loading…
Tenax Therapeutics, Inc. is projected to rise to $12.73 by 2027, a +7% move from its current price of $11.88. TENX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $11.52 | $11.87 | $12.24 | -0.05% |
| May 30 | $11.37 | $11.87 | $12.38 | -0.11% |
| May 31 | $11.26 | $11.86 | $12.50 | -0.16% |
| Jun 1 | $11.16 | $11.85 | $12.59 | -0.22% |
| Jun 2 | $11.08 | $11.85 | $12.67 | -0.27% |
| Jun 3 | $11.00 | $11.84 | $12.75 | -0.33% |
| Jun 4 | $10.93 | $11.83 | $12.82 | -0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.93 | $11.83 | $12.82 | -0.38% |
| Week 2 | $10.53 | $11.79 | $13.19 | -0.77% |
| Week 3 | $10.23 | $11.74 | $13.48 | -1.15% |
| Week 4 | $9.98 | $11.70 | $13.72 | -1.52% |
| Week 5 | $9.75 | $11.65 | $13.92 | -1.90% |
| Week 6 | $9.55 | $11.61 | $14.11 | -2.28% |
| Week 7 | $9.37 | $11.56 | $14.28 | -2.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tenax Therapeutics, Inc. is a development-stage pharmaceutical company focused on cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.
The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Tenax Therapeutics, Inc. (TENX) currently trades at $12.13 with a market cap of $321.75M and is ranked 3457. The current price and market position place it among smaller-cap healthcare names.
The near-to-long-term forecast shows a path of rising averages from 2026 onward, with a shift to bullish sentiment from the late-2020s and substantial upside potential by 2030 and beyond.
A major floor 22.7% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 27.2% above — a clean break opens room to run.
A major ceiling 38.5% above — clearing it would confirm fresh momentum.
Key TENX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TENX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.07 | Sell | $11.98 | Sell |
| MA 10 | $11.92 | Sell | $12.03 | Sell |
| MA 20 | $12.16 | Sell | $12.34 | Sell |
| MA 50 | $13.61 | Sell | $12.91 | Sell |
| MA 100 | $13.44 | Sell | $12.58 | Sell |
| MA 200 | $10.62 | Buy | $11.32 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.39 | Neutral |
| Stoch RSI (14) | 57.71 | Neutral |
| CCI (20) | -47.54 | Neutral |
| Williams %R (14) | -54.24 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 1.89 | Buy |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 45.76 | Neutral |
| TRIX (15) | -0.61 | Sell |
| Awesome (5,34) | -0.97 | Sell |
| Ultimate (7,14,28) | 46.80 | Neutral |
| Momentum (10) | -0.29 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 12.14 | Sell |
| ADX (14) | 15.47 | Neutral |
| ATR (14) | 0.34 | Info |
The 30-day technical picture is characterized by a bullish stance, with a 30-day range of $9.84 to $14.96. RSI14 sits at 40, while the 50-day simple moving average is $13.69 and the 200-day simple moving average is $10.56. Near-term support is at $11.48 and resistance at $15.11.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.69 | $11.88 | $15.34 | 0% | Neutral | |
| $9.99 | $12.73 | $17.23 | +7% | Neutral | |
| $10.47 | $13.74 | $19.34 | +16% | Neutral | |
| $12.81 | $17.25 | $25.03 | +45% | Bullish | |
| $14.84 | $20.43 | $30.42 | +72% | Bullish | |
| $13.92 | $19.57 | $29.80 | +65% | Bullish | |
| $14.25 | $20.42 | $31.74 | +72% | Bullish | |
| $15.16 | $22.13 | $35.03 | +86% | Bullish | |
| $14.65 | $21.76 | $35.03 | +83% | Bullish | |
| $17.93 | $27.08 | $44.28 | +128% | Bullish | |
| $19.88 | $32.39 | $56.55 | +173% | Bullish | |
| $40.18 | $74.78 | $143.63 | +529% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $10.69 | $11.88 | $13.99 | +0.00% |
| June 2026 | $9.97 | $11.73 | $14.16 | -1.25% |
| July 2026 | $9.51 | $11.30 | $13.84 | -3.68% |
| August 2026 | $9.60 | $11.49 | $14.23 | +1.65% |
| September 2026 | $9.87 | $11.88 | $14.85 | +3.45% |
| October 2026 | $9.69 | $11.73 | $14.79 | -1.28% |
| November 2026 | $9.54 | $11.61 | $14.74 | -1.04% |
| December 2026 | $9.82 | $12.00 | $15.34 | +3.35% |
Click any year to see its month-by-month TENX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TENX is projected to trade between $10.69 and $15.34, averaging $11.88 — a potential gain of 0% from today's $11.88. Price action looks broadly range-bound.
Tenax Therapeutics, Inc.'s 2027 outlook centres on $12.73, within a $9.99 to $17.23 range. That is up +7% on the projected 2026 average. That marks a +7% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, TENX could reach as high as $19.34, with a base case around $13.74 and support toward $10.47 — roughly +16% from $11.88. Price action looks broadly range-bound.
Expect TENX to range from $12.81 to $25.03 through 2029. The $17.25 average target implies a +45% move from current prices. That is up +26% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The TENX price prediction for 2030 points to an average of $20.43 (low $14.84, high $30.42) — a potential gain of +72% on today's $11.88. Momentum favours further upside here.
In 2031, TENX is projected to trade between $13.92 and $29.80, averaging $19.57 — a potential gain of +65% from today's $11.88. That is -4% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Tenax Therapeutics, Inc.'s 2032 outlook centres on $20.42, within a $14.25 to $31.74 range. That is up +4% on the projected 2031 average. That marks a +72% change versus current levels. Momentum favours further upside here.
By 2033, TENX could reach as high as $35.03, with a base case around $22.13 and support toward $15.16 — roughly +86% from $11.88. Buyers look set to stay in control over this stretch.
Expect TENX to range from $14.65 to $35.03 through 2034. The $21.76 average target implies a +83% move from current prices. That is -2% versus the projected 2033 average. Momentum favours further upside here.
The TENX price prediction for 2035 points to an average of $27.08 (low $17.93, high $44.28) — a potential gain of +128% on today's $11.88. Buyers look set to stay in control over this stretch.
In 2040, TENX is projected to trade between $19.88 and $56.55, averaging $32.39 — a potential gain of +173% from today's $11.88. That is up +20% on the projected 2035 average. Momentum favours further upside here.
Tenax Therapeutics, Inc.'s 2050 outlook centres on $74.78, within a $40.18 to $143.63 range. That is up +131% on the projected 2040 average. That marks a +529% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in TENX today (≈ 84.175084 TENX) could be worth
$6,294.79
+$5,294.79 (+529%) by 2050 · US Dollar
Based on the average projected TENX price of $74.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TENXwould be worth at today's price.
$1,000 invested in TENX on May 27, 2025 (≈ 165.289251 TENX) would be worth
$1,963.64
+$963.64 (+96.4%) today · 1.96× · US Dollar
Based on a TENX entry price of $6.05 vs. today's $11.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12 | $990 | -1.0% |
| 1 month ago | $15.11 | $786.23 | -21.4% |
| 3 months ago | $11.75 | $1,011.06 | +1.1% |
| 6 months ago | $9.43 | $1,259.81 | +26.0% |
| 1 year ago | $6.05 | $1,963.64 | +96.4% |
| All time (5.0y) ago | $3,120 | $3.81 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TENX forecast.
Our base-case forecast reaches $24.00 around 2035.
Implied market cap at $24.00: $636.6M
The year-by-year forecast shows a progressive upside through 2030 and beyond. In 2026, the average forecast is $12.13 with a min of $10.69 and a max of $15.82, and ROI of 0% with a neutral sentiment. By 2029 the average rises to $17.98 with a min of $13.22, a max of $26.39, ROI 48.2%, and a bullish sentiment.
The 2030 forecast sits at an average of $21.10 with a min of $15.15, a max of $31.82, ROI 74%, and a bullish outlook. The sequence continues through 2035 ($28.32 avg, ROI 133.5%), 2040 ($33.56 avg, ROI 176.6%), and culminates in 2050 with an average of $78.61, a max of $154.39, ROI 548%, and a bullish sentiment.
Tap a question to reveal the answer.
The 2030 average is $21.10 with a min of $15.15, a max of $31.82, ROI 74%, and a bullish sentiment.
Forecasts indicate substantial long-term upside with a bullish path from 2029 onward, including a 2030 average of $21.10 and a 2050 max of $154.39 with ROI up to 548%. These figures are estimates and not guarantees.
Yes. The 2040 max is $59.71, which exceeds $50, and the 2050 max is $154.39.
Current price is $12.13 and market cap is $321.75M.
The 30-day range is $9.84–$14.96, RSI14 is 40, SMA50 is $13.69, SMA200 is $10.56, with near-term support at $11.48 and resistance at $15.11, and a bullish overall technical stance.
Tenax Therapeutics, Inc. Community Discussion
0Share your Tenax Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.